Romania's Antibiotice Iasi inaugurates 2.5 MW photovoltaic facility
Antibiotice Iasi has inaugurated a 2.5 MW photovoltaic facility, a project funded by the Romanian Recovery and Resilience Plan (RRP).
Antibiotice Iasi has inaugurated a 2.5 MW photovoltaic facility, a project funded by the Romanian Recovery and Resilience Plan (RRP).
Antibiotice Iași Company, a pharmaceutical manufacturer with Romanian capital, became a member of the Sustainable Romania Coalition, the first platform for sustainable development established by the Embassy of Sustainability in Romania (ASR).
The state-owned drug manufacturer Antibiotice Iași made total investments worth RON 27.17 million (€5.4 million) in the first six months of the year for sustainable development.
Antibiotice Iaşi Company, the largest Romanian producer of generic drugs, will build a 2.5 MW photovoltaic plant. The company announced that it obtained from the Ministry of Investments and European Projects financing of RON4.08 million (€816,000) in this regard.
The Polish government has submitted to parliament a long-awaited draft amendment to the legislation governing onshore wind farm investments.
Eurowind Energy and Autoliv, a global leader in automotive safety systems, have signed a 12-year Power Purchase Agreement (PPA) in Romania.
Polski Holding Nieruchomości (PHN) has secured €8 million in preferential financing from the National Fund for Environmental Protection and Water Management for an 18 MW photovoltaic (PV) installation.
PPC Group has announced a €5.75 billion strategic investment initiative aimed at converting former lignite mining areas in Western Macedonia into a major center for green energy and technology.
The European Bank for Reconstruction and Development (EBRD) is providing an additional loan of up to €72 million to BIG CEE as part of a €100 million envelope of loans to support its expansion in Serbia and the Western Balkans.